VTVT vTv Therapeutics Inc.
Healthcare$33.16-3.62%ClosedMarket Cap: $86.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.22
P/S
2.44
EV/EBITDA
4.17
DCF Value
$10.43
FCF Yield
-11.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-8.3%
Net Margin
6.1%
ROE
4.0%
ROA
2.3%
ROIC
-3.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $36.8M | 100.0% | $23.3M | $24.1M | $— | — |
| Q4 null | $0.00 | NaN% | $-7.9M | $-7.1M | $— | — |
| FY null | $0.00 | NaN% | $-32.8M | $-27.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-10.7M | $-8.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-7.7M | $-6.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-6.5M | $-5.1M | $— | — |
| Q4 null | $17.0K | -29.4% | $-4.9M | $-3.6M | $— | — |
| FY null | $1.0M | 100.0% | $-24.2M | $-18.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-6.5M | $-4.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-7.2M | $-5.2M | $— | — |
| Q1 null | $1.0M | 100.0% | $-5.6M | $-4.9M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-4.7M | $-3.5M | $-1.67 | — |